Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • Invest with CPF/SRS
    • Singapore Stocks
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
HK StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

IMMUNOTECH-B

5.360
-0.010-0.19%
Volume:1.45M
Turnover:7.86M
Market Cap:2.76B
PE:-13.48
High:5.630
Open:5.540
Low:5.200
Close:5.370
52wk High:6.150
52wk Low:1.500
Shares:515.00M
HK Float Shares:514.58M
Volume Ratio:0.75
T/O Rate:0.28%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.398
ROE:-242.61%
ROA:-17.94%
PB:-17.71
PE(LYR):-13.48
PS:- -

Loading ...

OverviewCompanyNewsFilings

Concept

Nonprofit Pharmaceutical Companies-1.45%

Capital Flow

 
Inflow:
 
Outflow:
 
 
 
 
 
 
 
 
 
 
 
 
 
 

News

Jin Ying Fund's Ouyang Juan: China's Pharmaceutical Industry Upgrade Continues to Deliver, Focus on Innovative Drugs and Supply Chain

Deep News
·
8 hours ago

SIHUAN PHARM (00460): Subsidiary Huisheng Bio Receives IND Approval for Self-Developed GLP-1R/GCGR Dual-Target Innovative Drug P052 Injection

Stock News
·
10 hours ago

AI Computing Power Faces Volatility as Capital Rotates, Chemical and Healthcare Sectors Take the Lead, ETF 159363 Sees Fresh Buying Interest with 100% Pure Innovative Drug Index Launch

Deep News
·
Yesterday

Hong Kong Stocks Movement | CANBRIDGE-B (01228) Surges Over 19% Again, Cumulative Gains Exceed 20-fold This Year as Three Products Pass Initial Review for Commercial Insurance Innovative Drug Directory

Stock News
·
Yesterday

Analyst Rate

 
 
 
 

Corporate Actions

Financial Report Announcement
Aug 20, 2025
Financial Report Announcement
Mar 31, 2025 Post Market
Financial Report Announcement
Aug 23, 2024 Post Market
Financial Report Announcement
Mar 28, 2024
Financial Report Announcement
Aug 25, 2023

Dividend History

no data

No relevant data is available

Valuation Analysis

-11.31
Current
-10.08
Sector Average
28.20%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-11.31
Maximum
-2.74
+1 STD
-3.44
Minimum
-31.74
-1 STD
-16.73
Average
-10.08

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.